We are live on ! Find out more
KAS

Kestra Advisory Services Portfolio holdings

AUM $31B
1-Year Est. Return 28.39%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+28.39%
3 Year Est. Return
+85.12%
5 Year Est. Return
+94.26%
10 Year Est. Return
AUM
$7.88B
AUM Growth
-$749M
Cap. Flow
-$1.13B
Cap. Flow %
-14.37%
Top 10 Hldgs %
16.31%
Holding
2,130
New
285
Increased
609
Reduced
935
Closed
286

Sector Composition

Rank Sector Weight
1 Technology 10.39%
2 Financials 5.8%
3 Consumer Discretionary 5.32%
4 Healthcare 5.14%
5 Communication Services 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRAX
1826
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$55K ﹤0.01%
11,670
-6,500
-36% -$27.2K
NAT icon
1827
Nordic American Tanker
NAT
$1.38B
$49K ﹤0.01%
14,988
-3,119
-17% -$10.1K
NML
1828
Neuberger Energy Infrastructure and Income Fund Inc
NML
$593M
$48K ﹤0.01%
11,446
+139
+1% +$548
CALA
1829
DELISTED
Calithera Biosciences, Inc
CALA
$48K ﹤0.01%
1,000
CRBP icon
1830
Corbus Pharmaceuticals
CRBP
$166M
$46K ﹤0.01%
786
-139
-15% -$9.14K
ATRS
1831
DELISTED
Antares Pharma, Inc.
ATRS
$46K ﹤0.01%
11,264
-2,986
-21% -$12.9K
TCRT icon
1832
Alaunos Therapeutics
TCRT
$4.59M
$44K ﹤0.01%
81
-9
-10% -$5.6K
RMTI icon
1833
Rockwell Medical
RMTI
$28.4M
$43K ﹤0.01%
336
RNTX
1834
Rein Therapeutics
RNTX
$63.1M
$43K ﹤0.01%
1,500
NOVN
1835
DELISTED
Novan, Inc. Common Stock
NOVN
$42K ﹤0.01%
2,697
MUX icon
1836
McEwen Inc
MUX
$1.03B
$36K ﹤0.01%
3,505
-501
-13% -$5.5K
ABEV icon
1837
Ambev
ABEV
$48.1B
$34K ﹤0.01%
+12,565
New +$35.5K
CCO icon
1838
Clear Channel Outdoor Holdings
CCO
$1.23B
$34K ﹤0.01%
18,886
-316
-2% -$598
EVFM
1839
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$31K ﹤0.01%
+1,170
New +$53.2K
ECOR icon
1840
electroCore
ECOR
$54.8M
$30K ﹤0.01%
970
ATOS icon
1841
Atossa Therapeutics
ATOS
$20.6M
$29K ﹤0.01%
+913
New +$33.4K
VEON icon
1842
VEON
VEON
$3.62B
$28K ﹤0.01%
632
NYMX
1843
DELISTED
Nymox Pharmaceutical Corp
NYMX
$26K ﹤0.01%
11,532
TONX
1844
TON Strategy Co
TONX
$168M
$15K ﹤0.01%
1
-2
-67% -$30.6K
ACM icon
1845
Aecom
ACM
$9.3B
-4,623
Closed -$229K
ADNT icon
1846
Adient
ADNT
$1.65B
-12,301
Closed -$433K
ALTO icon
1847
Alto Ingredients
ALTO
$369M
-12,600
Closed -$72K
AMWL icon
1848
American Well
AMWL
$180M
-453
Closed -$244K
APYX icon
1849
Apyx Medical
APYX
$173M
-215,380
Closed -$1.61M
AVNS
1850
DELISTED
Avanos Medical
AVNS
-6,464
Closed -$298K

Similar funds

Kestra Advisory Services's Q1 2021 Portfolio in Review

As of Q1 2021, Kestra Advisory Services held 2,130 positions worth $7.88B, down 8.7% from $8.63B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Kestra Advisory Services withdrew a net $1.13B in Q1 2021, closing 286 positions and reducing 935 holdings. Its most notable exit was ProShares Ultra QQQ, an estimated $14.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Kestra Advisory Services opened a new position in LHA Market State Tactical Beta ETF worth $5.14M.

  • Kestra Advisory Services's largest Q1 2021 buy was LHA Market State Tactical Beta ETF: 178,971 shares worth $5.14M.
  • Kestra Advisory Services added most to Vanguard FTSE Developed Markets ETF in Q1 2021, an estimated $22.3M increase.
  • Kestra Advisory Services's biggest Q1 2021 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $67.6M.
  • Kestra Advisory Services fully exited ProShares Ultra QQQ in Q1 2021, selling an estimated $14.6M.
  • Kestra Advisory Services's ten largest holdings make up 16% of its $7.88B portfolio in Q1 2021.
  • Kestra Advisory Services opened 285 new positions and closed 286 in Q1 2021.
  • Kestra Advisory Services's portfolio value fell 8.7% quarter-over-quarter to $7.88B.

Based on Kestra Advisory Services's 13F filing for Q1 2021, filed 10 May 2021.